Utter Christine Marie

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
39
Insider Sells Sum
$7.54M

Insider Activity of Utter Christine Marie

According to the SEC Form 4 filings, Utter Christine Marie, being in a position of

  1. SVP, CHIEF ACCOUNTING OFFICER at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 22510 shares for $1.14M,
    over all time since 2018-01-04, has bought 0 shares, and sold 166525 shares for $7.54M.

The largest sale of all time was on 2023-03-27 and amounted to 26658 shares of PTC Therapeutics, Inc. for $1.2M.

Biography of Utter Christine Marie

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,142,1215100

Comparison of Insiders on Amount of Buys and Sells

2025-02-20SalePTC Therapeutics, Inc.
PTCT
SVP, CHIEF ACCOUNTING OFFICER
878
0.0011%
$50.12$44,009+4.62%
2025-02-19SalePTC Therapeutics, Inc.
PTCT
SVP, CHIEF ACCOUNTING OFFICER
879
0.0012%
$50.10$44,034+3.93%
2025-01-08SalePTC Therapeutics, Inc.
PTCT
SVP, CHIEF ACCOUNTING OFFICER
1,662
0.0021%
$44.50$73,959+10.8%
2025-01-07SalePTC Therapeutics, Inc.
PTCT
SVP, CHIEF ACCOUNTING OFFICER
1,291
0.0017%
$45.34$58,534+11.68%
2024-12-02SalePTC Therapeutics, Inc.
PTCT
SVP, CHIEF ACCOUNTING OFFICER
17,800
0.0226%
$51.77$921,585-7.7%
2024-01-30SalePTC Therapeutics, Inc.
PTCT
SVP, CHIEF ACCOUNTING OFFICER
318
0.0004%
$27.25$8,666+29.48%
2024-01-09SalePTC Therapeutics, Inc.
PTCT
SVP, FINANCE & CAO
1,653
0.0022%
$29.01$47,961+17%
2024-01-08SalePTC Therapeutics, Inc.
PTCT
SVP, FINANCE & CAO
1,188
0.0015%
$28.64$34,025+11.97%
2023-04-21SalePTC Therapeutics, Inc.
PTCT
SVP, FINANCE & CAO
4,692
0.0064%
$55.06$258,326-48%
2023-03-29SalePTC Therapeutics, Inc.
PTCT
SVP, FINANCE & CAO
4,688
0.0063%
$47.79$224,044-36.85%
2023-03-27SalePTC Therapeutics, Inc.
PTCT
SVP, FINANCE & CAO
26,658
0.0356%
$45.09$1.2M-32.85%
2023-01-31SalePTC Therapeutics, Inc.
PTCT
SVP, FINANCE & CAO
325
0.0004%
$45.63$14,829-12.4%
2023-01-11SalePTC Therapeutics, Inc.
PTCT
SVP, FINANCE & CAO
417
0.0005%
$44.36$18,498-10.8%
2023-01-10SalePTC Therapeutics, Inc.
PTCT
SVP, FINANCE & CAO
489
0.0006%
$42.93$20,994-7.73%
2023-01-09SalePTC Therapeutics, Inc.
PTCT
SVP, FINANCE & CAO
706
0.001%
$41.66$29,409-1.51%
2022-02-02SalePTC Therapeutics, Inc.
PTCT
SVP, Finance & CAO
707
0.001%
$40.38$28,549+4.37%
2022-02-01SalePTC Therapeutics, Inc.
PTCT
SVP, Finance & CAO
313
0.0004%
$40.00$12,521+0.52%
2022-01-18SalePTC Therapeutics, Inc.
PTCT
SVP, Finance & CAO
11,428
0.017%
$43.94$502,118-3.11%
2022-01-07SalePTC Therapeutics, Inc.
PTCT
SVP, Finance & CAO
747
0.0011%
$38.52$28,778+5.33%
2021-02-08SalePTC Therapeutics, Inc.
PTCT
SVP, Finance & CAO
2,657
0.0039%
$66.00$175,362-36.49%
Total: 39
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.